Skip to content

Clinical trials

Completed Cardiovascular Diseases trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Completed Country / region: Hong Kong Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20061
20082
20091
20102
20131
20141
20161
20171
20183
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong3
Boston Scientific Corporation2
GlaxoSmithKline2
Novartis Pharmaceuticals2
The University of Hong Kong2
Amgen1
AstraZeneca1
Boehringer Ingelheim1
CSL Behring1
Hamilton Health Sciences Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases18
Atherosclerosis3
Heart Diseases3
Heart Failure3
Acute Coronary Syndrome2
Atrial Fibrillation2
Coronary Artery Disease2
Myocardial Infarction2
Stroke2
Anemia1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.